Teleflex (TFX) Gets a Hold from RBC Capital
RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Teleflex on January 7 and set a price target of $135.00. The company’s shares closed yesterday at $126.53.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Singh Chadha covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Insulet, and Edwards Lifesciences. According to TipRanks, Singh Chadha has an average return of 3.2% and a 54.38% success rate on recommended stocks.
Currently, the analyst consensus on Teleflex is a Hold with an average price target of $137.20.
Based on Teleflex’s latest earnings release for the quarter ending September 28, the company reported a quarterly revenue of $913.02 million and a GAAP net loss of $408.89 million. In comparison, last year the company earned a revenue of $764.38 million and had a net profit of $111 million
Read More on TFX:
Disclaimer & DisclosureReport an Issue
- Teleflex: Leadership Transition, Reduced Guidance, and Portfolio Divestitures Justify Continued Hold Rating
- Teleflex falls -13.0%
- Teleflex down 11% to $112 after lowering FY25 revenue outlook
- Teleflex cuts FY25 revenue view to $3.27B-$3.278B from $3.305B-$3.32B
- Teleflex Announces CEO Transition Amid Strategic Portfolio Shift
